ADMA Biologics Inc Common Stock
ADMA US0008991046
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-33% | 164% | 17% | 277% | 3% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Grossman Adam S CEO |
16.13 USD |
15,000 Sold |
241,950 USD |
15/09/2025 | 15/09/2025 |
Grossman Adam S CEO |
16.13 USD |
6,000 Sold |
96,780 USD |
15/09/2025 | 15/09/2025 |
Grossman Adam S CEO |
16.88 USD |
15,000 Sold |
253,200 USD |
15/08/2025 | 15/08/2025 |
Grossman Adam S CEO |
16.88 USD |
6,000 Sold |
101,280 USD |
15/08/2025 | 15/08/2025 |
Grossman Adam S CEO |
18.66 USD |
6,000 Sold |
111,960 USD |
15/07/2025 | 15/07/2025 |
Grossman Adam S CEO |
18.66 USD |
15,000 Sold |
279,900 USD |
15/07/2025 | 15/07/2025 |
Elms Steve |
20.24 USD |
194,749 Sold |
3,941,720 USD |
12/06/2025 | 16/06/2025 |
Grossman Adam S CEO |
20.81 USD |
15,000 Sold |
312,150 USD |
16/06/2025 | 16/06/2025 |
Grossman Adam S CEO |
20.81 USD |
6,000 Sold |
124,860 USD |
16/06/2025 | 16/06/2025 |
Elms Steve |
20.82 USD |
137,931 Sold |
2,871,723 USD |
12/06/2025 | 13/06/2025 |